期刊文献+

弥漫大B细胞淋巴瘤继发第二肿瘤三例并文献复习 被引量:2

原文传递
导出
摘要 目的提高对弥漫大B细胞淋巴瘤(DLBCL)治疗后继发第二肿瘤的认识。方法收集山西省肿瘤医院1993年1月至2010年12月收治的3例DLBCL继发第二肿瘤患者临床资料并行回顾性分析,同时结合文献加以讨论。结果3例DLBC患者中,2例治疗后分别继发白血病、肝癌,为异时性多原发恶性肿瘤;1例继发食管癌,为同时性多原发恶性肿瘤。结论DLBCL合并第二肿瘤患者疗效差,治疗后要长期密切随访,对第二肿瘤要尽可能早期发现、早期诊断、早期治疗。
出处 《白血病.淋巴瘤》 CAS 2012年第3期179-180,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献9

  • 1Hans CP, Weisnburger DD, Greimer TC, et al. Confirmation of the molecular classification of diffuse large B ce |ymphoma by inmmunohistochemistry using a tissue microm'ry. Blood, 2004, 103: 275-282.
  • 2Sacchi S, Marcheselli L, Bari A, et al. Second malignancies after treatment of diffuse large B-cell non-Hodgkin' s lymphoma: a GISL cohort study. Haematologica, 2008,93 : 1335-1342.
  • 3张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:195
  • 4Friedberg JW. Secondary malignancies after therapy of indolent non- Hodgkin's lymphoma. Haematologica, 2008, 93 : 336-338.
  • 5Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA, 2003, 290:465-475.
  • 6van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose,chemotherapy,and hormonal factors in breast cancer following Hodgkin's disease.J Natl Cancer lnst, 2003, 95:971-980.
  • 7Bluhm EC, Ronckers C, Hayashi ILl, et al .Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the childhood cancer survivor study. Blood, 2008, 111:4014- 4021.
  • 8吴月兵,王远惠,彭莉,柯玉华,余伟江.多原发恶性肿瘤7例临床分析[J].肿瘤预防与治疗,2010,23(2):153-155. 被引量:5
  • 9刘霞,王华庆.应重视淋巴瘤治疗后的长期毒性[J].白血病.淋巴瘤,2010,19(11):641-645. 被引量:2

二级参考文献61

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:33
  • 2郑智,潘铁成,汤应雄,赵金平,李军,付向宁,陈启福.合并肺癌的双原发恶性肿瘤11例分析[J].肿瘤防治研究,2005,32(8):507-508. 被引量:3
  • 3张怡梅,倪海英,朱严冰,孟冀昌,苏同义.重复癌16例临床分析[J].临床误诊误治,2006,19(12):53-55. 被引量:13
  • 4王建设,章龙珍.23例重复癌临床分析[J].徐州医学院学报,2007,27(6):383-386. 被引量:12
  • 5Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 7Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.
  • 8Felay J, Bnrkhard C, Whelan S, et al. Check and conversion programs for cancerregistries. IARC Technical Report No. 42[M]. Lyon: IARC, 2005.
  • 9Felay J. The IARCcrgTools program [EB/OL]. http://www.iacr.com.fr/iarccrgtools.htm, 2006.
  • 10赵平,陈万青.2008年中国肿瘤登记年报[M].第1版.北京:军事医学科学出版社,2009.88-89.

共引文献199

同被引文献5

  • 1Guerrero MA,Ballard BR,Grau AM. Malignant phylodes tulnor of the breast:review of the literature and case report of stranmal overgrowth[J].Surg Oncal,2003.27-37.
  • 2Ros JC,Tapia O,Carrasco P. Prognstie factors of phyliodes tumor of the breast[J].{H}Pathology International,2006.309-314.
  • 3Yamasaki R,Yokota K,Okada H. Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue(MALT) lymphoma[J].{H}Journal of Medical Microbiology,2004.21-29.
  • 4Asenjo LM,Gisbert JP. Prevalence of Helicobacter pylon intection in gastric MALT lymphoma a systenatic review[J].Rev Esp Dig,2007.398-404.
  • 5陈金良,姜葵,张继平,温冰,张建中,章明放,王邦茂.幽门螺杆菌复燃或再感染致胃MALT淋巴瘤复发一例[J].中华医学杂志,2008,88(22):1581-1581. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部